MEK and RAF inhibitors: time for a paradigm shift in the treatment of pediatric low-grade gliomas?

<span class="paragraphSection">See article in this issue by Sun et al., pp. 774–785.</span>

from Cancer via ola Kala on Inoreader http://ift.tt/2r4p1Ni
via IFTTT